Successful treatment of T315I BCR-ABL mutated lymphoid blast phase chronic myeloid leukemia with chimeric antigen receptor T cell therapy followed by dasatinib

Detalles Bibliográficos
Autores principales: Zhang, Hao, Hu, Yongxian, Chang, Alex H., Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965727/
https://www.ncbi.nlm.nih.gov/pubmed/31988993
http://dx.doi.org/10.1016/j.reth.2019.11.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965727/
https://www.ncbi.nlm.nih.gov/pubmed/31988993
http://dx.doi.org/10.1016/j.reth.2019.11.003

Ejemplares similares